Target intelligence / Profile preview

Oral microbiota balance

01

Overview

The term "oral microbiota balance" refers to the stable and diverse community of microorganisms residing in the oral cavity, primarily bacteria but also including fungi, viruses, protozoa, and archaea. This equilibrium, sometimes called eubiosis, supports oral health by preventing colonization and growth of pathogenic microorganisms, facilitating tissue remineralization, modulating immune responses, and eliminating toxins or free radicals. Disruption of this balance, known as dysbiosis, can lead to oral diseases like dental caries, gingivitis, and periodontitis, as well as systemic illnesses through inflammation and microbial migration. It is not a singular molecular entity or receptor, but rather a collective property of the oral microbial ecosystem. Therapeutic strategies (e.g., probiotics, microbiota transplantation, dietary modification) aim to restore or maintain this balance; however, it is not considered a druggable target in the conventional sense. Monitoring microbial composition and certain biomarkers can help assess risk and efficacy of interventions. In summary: "Oral microbiota balance" describes a physiological state, not a defined molecular target, and should be used to refer to ecological stability in the oral microbial community rather than as a therapeutic target.

Other names
Oral microbiome balanceOral eubiosisOral microbial homeostasis
02

Mechanism of action

Balance is affected by therapies that promote beneficial microbes or reduce pathogenic ones, such as probiotics, prebiotics, microbiota transplantation, oral hygiene practices, antibiotic usage.

03

Biological functions

Maintenance of oral healthProtection against pathogenic microbesSupport for remineralization of teethRegulation of immune responses
04

Disease associations

Infection (e.g., dental caries, periodontitis, gingivitis)InflammationPotentially linked with systemic diseases (cardiovascular disease, diabetes, rheumatoid arthritis, neurodegenerative disorders, cancer)
05

Safety considerations

Antibiotic resistanceUnintended disruption of beneficial microbial communitiesUncertain long-term outcomes of microbiota transplantationRisk of introducing pathogenic organisms during biological interventions
06

Interacting drugs

Probiotics

2 more in the full profile.

07

Biomarkers

Diversity indices of oral microbiotaRatios or abundance of specific bacterial species (e.g., reduction in Streptococcus mutans or Porphyromonas gingivalis)Levels of inflammatory cytokines following OMT

Beyond the preview

Go deeper on Oral microbiota balance.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Oral microbiota balance.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call